CAD 15.8
(-1.56%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.32 Billion CAD | 6.09% |
2022 | 1.24 Billion CAD | 3.52% |
2021 | 1.2 Billion CAD | -2.22% |
2020 | 1.23 Billion CAD | 5.9% |
2019 | 1.16 Billion CAD | -1.98% |
2018 | 1.18 Billion CAD | 18.71% |
2017 | 998.65 Million CAD | 10.47% |
2016 | 904.01 Million CAD | 16.71% |
2015 | 774.59 Million CAD | 3.61% |
2014 | 747.58 Million CAD | 3.18% |
2013 | 724.53 Million CAD | 34.2% |
2012 | 539.91 Million CAD | 16.48% |
2011 | 463.52 Million CAD | 12.62% |
2010 | 411.56 Million CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.32 Billion CAD | 0.16% |
2024 Q2 | 1.34 Billion CAD | 1.74% |
2023 Q4 | 1.32 Billion CAD | 2.39% |
2023 Q1 | 1.26 Billion CAD | 1.45% |
2023 FY | 1.32 Billion CAD | 6.09% |
2023 Q3 | 1.29 Billion CAD | 1.59% |
2023 Q2 | 1.27 Billion CAD | 0.54% |
2022 Q4 | 1.24 Billion CAD | -2.55% |
2022 Q3 | 1.27 Billion CAD | 0.24% |
2022 Q2 | 1.27 Billion CAD | 6.01% |
2022 Q1 | 1.2 Billion CAD | -0.03% |
2022 FY | 1.24 Billion CAD | 3.52% |
2021 Q3 | 1.18 Billion CAD | 2.23% |
2021 Q2 | 1.16 Billion CAD | -0.85% |
2021 Q1 | 1.17 Billion CAD | -4.61% |
2021 FY | 1.2 Billion CAD | -2.22% |
2021 Q4 | 1.2 Billion CAD | 1.12% |
2020 Q2 | 1.34 Billion CAD | 11.49% |
2020 Q4 | 1.23 Billion CAD | -2.5% |
2020 Q3 | 1.26 Billion CAD | -5.88% |
2020 Q1 | 1.2 Billion CAD | 3.5% |
2020 FY | 1.23 Billion CAD | 5.9% |
2019 Q3 | 1.16 Billion CAD | 0.03% |
2019 Q2 | 1.16 Billion CAD | -1.13% |
2019 FY | 1.16 Billion CAD | -1.98% |
2019 Q1 | 1.18 Billion CAD | -0.32% |
2019 Q4 | 1.16 Billion CAD | -0.57% |
2018 Q4 | 1.18 Billion CAD | 1.56% |
2018 Q3 | 1.16 Billion CAD | -3.92% |
2018 Q2 | 1.21 Billion CAD | 1.63% |
2018 Q1 | 1.19 Billion CAD | 19.71% |
2018 FY | 1.18 Billion CAD | 18.71% |
2017 FY | 998.65 Million CAD | 10.47% |
2017 Q4 | 998.65 Million CAD | 7.32% |
2017 Q3 | 930.58 Million CAD | 1.55% |
2017 Q2 | 916.34 Million CAD | -0.1% |
2017 Q1 | 917.27 Million CAD | 1.47% |
2016 Q2 | 896.76 Million CAD | 16.52% |
2016 Q3 | 907.56 Million CAD | 1.2% |
2016 Q4 | 904.01 Million CAD | -0.39% |
2016 FY | 904.01 Million CAD | 16.71% |
2016 Q1 | 769.59 Million CAD | -0.64% |
2015 Q2 | 738.8 Million CAD | -0.23% |
2015 Q4 | 774.59 Million CAD | 5.98% |
2015 Q3 | 730.89 Million CAD | -1.07% |
2015 Q1 | 740.49 Million CAD | -0.95% |
2015 FY | 774.59 Million CAD | 3.61% |
2014 FY | 747.58 Million CAD | 3.18% |
2014 Q4 | 747.58 Million CAD | 0.1% |
2014 Q3 | 746.83 Million CAD | 0.41% |
2014 Q2 | 743.76 Million CAD | -0.66% |
2014 Q1 | 748.73 Million CAD | 3.34% |
2013 Q1 | 548.63 Million CAD | 1.62% |
2013 Q4 | 724.53 Million CAD | 12.4% |
2013 Q3 | 644.6 Million CAD | -1.61% |
2013 FY | 724.53 Million CAD | 34.2% |
2013 Q2 | 655.17 Million CAD | 19.42% |
2012 FY | 539.91 Million CAD | 16.48% |
2012 Q4 | 539.91 Million CAD | -1.98% |
2012 Q1 | 467.9 Million CAD | 0.94% |
2012 Q2 | 544.06 Million CAD | 16.28% |
2012 Q3 | 550.81 Million CAD | 1.24% |
2011 Q3 | 470.43 Million CAD | 2.22% |
2011 Q4 | 463.52 Million CAD | -1.47% |
2011 FY | 463.52 Million CAD | 12.62% |
2011 Q1 | 411.74 Million CAD | 0.04% |
2011 Q2 | 460.21 Million CAD | 11.77% |
2010 Q2 | 409.79 Million CAD | 0.0% |
2010 FY | 411.56 Million CAD | 0.0% |
2010 Q3 | 414.42 Million CAD | 1.13% |
2010 Q4 | 411.56 Million CAD | -0.69% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
CareRx Corporation | 150.36 Million CAD | -778.898% |
dentalcorp Holdings Ltd. | 1.55 Billion CAD | 14.902% |
Extendicare Inc. | 584.81 Million CAD | -125.983% |
Numinus Wellness Inc. | 10.28 Million CAD | -12751.607% |
WELL Health Technologies Corp. | 563.15 Million CAD | -134.672% |